What are the new treatments for muscular polyarteritis nodosa and muscular polyarteritis nodosa with fasciitis?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18740091
Cited by: 0

Abstract

Emerging treatments for muscular polyarteritis nodosa include biologic agents like tocilizumab and adalimumab, especially in refractory cases, though corticosteroids remain the mainstay. Newer options like baricitinib show promise, but further research is needed to confirm their role.

Fields of Study & Subjects

Vasculitis and related conditions Autoimmune and Inflammatory Disorders Otitis Media and Relapsing Polychondritis

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
23 February 2026
Language
EN